Modern drugs for obesity and metabolic syndrome treatment (Review)
The article reviews modern anti-obesity drugs to identify new trends in effective and safe risk factors reduction (diabetes, cardiovascular and musculoskeletal diseases, cancer). Some anti-obesity drugs have a high risk of adverse effects on the CNS and cardiovascular system, so they should be used...
Saved in:
| Main Authors: | M. L. Maximov, O. V. Dralova, V. G. Kukes, V. N. Chubarev, V. V. Tarasov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
2016-12-01
|
| Series: | Сеченовский вестник |
| Subjects: | |
| Online Access: | https://www.sechenovmedj.com/jour/article/view/575 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity and arterial hypertension. Part I: weight reduction and blood pressure normalisation
by: S. V. Nedogoda, et al.
Published: (2008-10-01) -
Medical treatment of obesity: peculiarities of medical treatments, information, responsibility and relation to medical treatment of obesity of patients
by: O. V. Lerman, et al.
Published: (2019-08-01) -
EVALUATION OF WEIGHT REDUCTION EFFICACY AND SAFETY OF SIBUTRAMIN-CONTAINING DRUGS IN PATIENTS WITH ALIMENTARY OBESITY
by: T. Yu. Demidova, et al.
Published: (2022-07-01) -
Sibutramine monotherapy in arterial hypertension combined with obesity
by: S. V. Nedogoda, et al.
Published: (2009-08-01) -
Obesity pharmaceutical correction in metabolic syndrome patients
by: V. B. Mychka, et al.
Published: (2005-08-01)